Superluminal Medicines

0 reviews

Superluminal Medicines is a Boston-based generative biology and chemistry company dedicated to transforming drug discovery and development. By integrating deep expertise in biology and chemistry with advanced machine learning and proprietary big data infrastructure, the company accelerates the creation of candidate-ready compounds. Its predict-design-test architecture accurately models protein structures and designs highly selective compounds to induce precise structural changes for therapeutic effects. The discovery engine is further enhanced by an industry-leading in silico pharmacokinetic and toxicology prediction capability. Superluminal's proprietary pipeline focuses on high-value G protein-coupled receptor (GPCR) targets, aiming to deliver innovative treatments with unprecedented speed and accuracy.